Literature DB >> 2902006

In defense of traditional antihypertensive therapy.

M Moser1.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 2902006     DOI： 10.1161/01.hyp.12.3.324

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  4 in total

Review 1.  Do angiotensin converting enzyme inhibitors represent a progress in hypertension care in diabetes mellitus?

Authors:  P T Sawicki; I Mühlhauser; T Baba; M Berger
Journal:  Diabetologia       Date:  1990-02       Impact factor: 10.122

2.  The costs of treating hypertension.

Authors:  M Moser
Journal:  Cardiovasc Drugs Ther       Date:  1989-10       Impact factor: 3.727

3.  Should the costs of development inhibit research into new antihypertensive drugs?

Authors:  J I Robertson
Journal:  Cardiovasc Drugs Ther       Date:  1989-10       Impact factor: 3.727

4.  Do resident and staff physicians differ in the types and costs of antihypertensive drugs they select?

Authors:  T H Payne; J D Goodson; M M Morgan; G O Barnett
Journal:  J Gen Intern Med       Date:  1991 Sep-Oct       Impact factor: 5.128
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.